T. Rowe Price US Smlr Cm Eq In CHF 1Register to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | - | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 21/11/2024 | CHF 11.08 | |
Day Change | 1.42% | |
Morningstar Category™ | Other Equity | |
ISIN | LU2818149077 | |
Fund Size (Mil) 21/11/2024 | USD 4945.78 | |
Share Class Size (Mil) 21/11/2024 | CHF 0.03 | |
Max Initial Charge | - | |
Ongoing Charge 24/10/2024 | 0.66% |
Investment Objective: T. Rowe Price US Smlr Cm Eq In CHF 1 |
To increase the value of its shares, over the long term, through growth in the value of its investments. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Curt Organt 31/03/2019 | ||
Matt Mahon 01/09/2023 | ||
Inception Date 10/06/2024 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Russell 2500 Net 30% | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for T. Rowe Price US Smlr Cm Eq In CHF 1 | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Vontier Corp Ordinary Shares | Technology | 1.42 |
International Paper Co | Consumer Cyclical | 1.25 |
Teledyne Technologies Inc | Technology | 1.23 |
Bruker Corp | Healthcare | 1.16 |
Revvity Inc | Healthcare | 1.15 |
Increase Decrease New since last portfolio | ||
T. Rowe Price US Smlr Cm Eq In CHF 1 |